AbbVie Inc (ABBV)

NYSE
Currency in USD
Disclaimer
136.87
+3.43
(+2.57%)
Closed
136.60
-0.27
(-0.20%)
After Hours
Real-time Data
High dividend Yield
Day's Range
133.50
136.97
52 wk Range
131.10
168.11
Volume
6,518,516
Prev. Close
133.44
Open
133.71
Day's Range
133.5-136.97
52 wk Range
131.1-168.11
Volume
6,518,516
Average Volume (3m)
5,873,082
1-Year Change
-7%
Shares Outstanding
1,764,289,680
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
164.60
Upside +20.26%

People Also Watch

184.06
PEP
+1.03%
102.53
MMM
+8.75%
226.63
CAT
+8.40%
295.94
HD
+2.62%
156.97
JNJ
+1.57%

AbbVie Inc News

AbbVie Inc Analysis

AbbVie Inc Company Profile

AbbVie Inc. (AbbVie) is a diversified research-based biopharmaceutical company. The Company is engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers products in various therapeutic categories, including immunology products, which include Humira, Skyrizi and Rinvoq; oncology products, which include Imbruvica and Venclexta/Venclyxto; aesthetics products that include Botox Cosmetic, The Juvederm Collection of Fillers and others; neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; eye care products, which consists of Lumigan/Ganfort, Alphagan/Combigan and Restasis, and other key products, which include Mavyret/Maviret, Creon, Lupron, Linzess/Constella and Synthroid. Its products are sold to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from the AbbVie-owned distribution centers and public warehouses.

Employees
50000